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ABSTRACT
Purpose In the present study we investigated the root-cause of
an interference signal (100–200 nm) of sugar-containing solutions
in dynamic light scattering (DLS) and nanoparticle tracking analysis
(NTA) and its consequences for the analysis of particles in biophar-
maceutical drug products.
Methods Different sugars as well as sucrose of various purity
grades, suppliers and lots were analyzed by DLS and NTA before
and (only for sucrose) after treatment by ultrafiltration and
diafiltration. Furthermore, Fourier transform infrared (FTIR) mi-
croscopy, scanning electron microscopy coupled energy-
dispersive X-ray spectroscopy (SEM-EDX), and fluorescence
spectroscopy were employed.
Results The intensity of the interference signal differed be-
tween sugar types, sucrose of various purity grades, suppliers,
and batches of the same supplier. The interference signal
could be successfully eliminated from a sucrose solution by
ultrafiltration (0.02 μm pore size). Nanoparticles, apparently
composed of dextrans, ash components and aromatic color-
ants that were not completely removed during the sugar
refinement process, were found responsible for the interfer-
ence and were successfully purified from sucrose solutions.
Conclusions The interference signal of sugar-containing solutions
in DLS and NTA is due to the presence of nanoparticulate impu-
rities. The nanoparticles present in sucrose were identified as
agglomerates of various impurities originating from raw materials.
KEYWORDS Dynamic light scattering . Excipients . Impurities .
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ABBREVIATIONS
ATR Attenuated total reflection
AU Absorbance units
AUC Area under the curve
Da Dalton
DLS Dynamic light scattering
EDX Energy-dispersive X-ray spectroscopy
FTIR Fourier transform infrared spectroscopy
IgG Immunoglobulin type G
NTA Nanoparticle tracking analysis
PVDF Polyvinylidene fluoride
SEM Scanning electron microscopy
StDev Standard deviation
UV Ultra-violet
λEx/λEm Wavelength of excitation/emission
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INTRODUCTION
The safety and efficacy of a therapeutic protein depends in
part on its chemical and physical stability. Degradation, such
as aggregation, of a therapeutic protein can reduce the avail-
ability of the protein’s active form, can negatively affect its
pharmacokinetic properties and might cause adverse effects,
such as unwanted immunogenicity [1–3]. To enhance the
chemical and physical stability of a protein therapeutic, bio-
pharmaceutical drug products contain a combination of spe-
cific formulation additives to ensure the chemical and physical
stability of the therapeutic protein.
Among the many known excipients sugars, in particular
sucrose and trehalose are employed, because they are prefer-
entially excluded from the protein’s surface, thus, increasing
the free energy of the system and thereby promoting confor-
mational stability [4–6]. Examples of sugar-containing prod-
ucts on themarket are amongst others Enbrel®, Avastin® and
Stelara®. Sugars are also extensively used for lyophilized pro-
tein formulations as cryoprotectors and lyoprotectors, e.g.,
Herceptin®, Serostim® and Remicade [7]. As with all re-
agents that are approved for the use in pharmaceutical drug
products, testing procedures and purity criteria of sugars are
defined and regulated by the respective pharmacopeias.
Throughout the development of a therapeutic protein and
its respective drug product, particle analysis is performed to
assess product quality and protein stability. This practice has
received increasing attention during the past few years and
dynamic light scattering (DLS) became a commonly applied
tool for this task in various phases of development, e.g., for-
mulation screening, real-time or accelerated stability studies,
and forced degradation studies. The value of DLS analysis
comes from its wide size range it covers (from about a nano-
meter to several micrometers), the fast and easy performance,
and its high sensitivity towards larger species, such as protein
aggregates and particles [8, 9]. Despite its advantages, how-
ever, the analysis can be disturbed by the presence of certain
excipients, which scatter light in the relevant size range, such
as polysorbate micelles or sugar molecules. Sugar molecules
have, according to the literature, a size of about 0.5 and 1 nm
for mono- and disaccharides, respectively [10]. Interestingly,
however, a second signal appearing at around 100–200 nm
was consistently found when sugar-containing formulations
were analyzed by DLS. In 2007, Kaszuba et al. explained
the presence of this second signal as to be Bprobably due to
collective diffusion of the sucrose molecules^ [11]. Ever since,
academic and industrial researchers have referred to this sig-
nal as the intrinsic phenomenon of sugar interference with
DLS. Importantly, this interference marks a big challenge
for DLS when analyzing biopharmaceutical drug products,
because of difficulties in assessing the formation of aggregates
and particles in presence of a permanent signal at 100–
200 nm. It further impairs the ability to compare the stability
of a protein formulated with different sugars or varying sugar
content, e.g., during formulation development. Surprisingly
and despite all these issues, the origin of this interference was
never truly investigated.
Therefore, the present study was designed to understand
the root-cause of the sugar interference with DLS, and its
consequences for the analysis of particles in biopharmaceuti-
cal drug products. While all tested sugars (sucrose, trehalose,
fructose, maltose and galactose) exhibit an interference phe-
nomenon, we show on the example of sucrose that the inter-
ference is caused by the presence of actual nanoparticles,
which dramatically differ in amount, but less so in size, be-
tween suppliers and between batches of the same supplier. A
detailed characterization of these particles identified them as
impurities originating from raw materials that are not
completely removed during the refinement process. The
quantities of nanoparticles present in pharmaceutical-grade
sucrose were found to be up to 109 particles per gram, while
the product still can fulfill all requirements set by the current
U.S. and European pharmacopeias.
MATERIALS & METHODS
Materials
Lysozymewas purchased from Fluka (Buchs, Germany), and a
humanizedmonoclonal antibody, isotype IgG1 [12], was used
to model a therapeutic protein. Sucrose was purchased from
Sigma (Taufkirchen, Germany), Merck (Darmstadt, Germa-
ny), Caelo (Hilden, Germany), VWR (Bruchsal, Germany)
and donated by Südzucker (Mannheim, Germany). PVDF
syringe filters with a pore size of 0.2 and 0.1 μmwere obtained
fromMillipore (Schwalback, Germany), Anotop syringe filters
with a pore size of 0.02 μm were obtained from GE Life
Science (Freiburg, Germany).
Sample preparation
All saccharides were dissolved inMilli-Q®water (Millipore) at
stated concentrations in percent weight per volume (% w/v).
Protein (IgG or lysozyme) was dissolved in a 7% sucrose solu-
tion to achieve the desired concentrations. If not stated differ-
ently, all solutions were filtered through a 0.2-μm PVDF sy-
ringe filter.
Diafiltration
A Minimate II Tangential Flow Filtration (TFF) system (Pall,
Crailsheim, Germany) equipped with a 30 kDa TFF capsule
(Pall) was used to perform diafiltration on 700 mL of an aque-
ous sucrose G solution (50% w/v). Diafiltration against Milli-
Q® water was performed until the permeate volume reached
2420 Weinbuch et al.
14 times the feed volume. The last filtrate volume was ana-
lyzed by DLS and did not show any residual sucrose peaks.
The residual sucrose monomer concentration after
diafiltration (cDF) was calculated as 0.3 mg/L, according to
Eq. (1):
cD F ¼ cI ⋅e−N ð1Þ
where cI is the initial sucrose monomer concentration, N the
number of diavolumes, and where no retention of the sucrose
monomer by the TFF membrane is assumed. Subsequently,
the retenate was concentrated by first using TFF and then 10-
kDa centrifugal filter-units (Amicon Ultra 15, Millipore) to a
final volume of ca. 0.8 mL. As a control, Milli-Q® water
without the addition of sucrose was treated the same way.
Dynamic Light Scattering (DLS)
DLS measurements were performed with a Zetasizer Nano
ZS system (Malvern, Herrenberg, Germany) equipped with a
633 nm He-Ne laser. The scattered light was detected by
using non-invasive backscatter detection at an angle of 173°.
A sample volume of 500 μL was analyzed in single-use poly-
styrene semi-micro cuvettes with a path length of 10 mm
(Brand, Wertheim, Germany). The Dispersion Technology
Software version 6.01 was used for data collection and analy-
sis. If not stated differently, the measurements were made with
an automatic attenuator and a controlled temperature of
25°C. The intensity size distribution, Z-average diameter, de-
rived count rate, and polydispersity index were calculated
from the autocorrelation function obtained in ’general pur-
pose mode’. Each sample was measured in triplicate.
Nanoparticle Tracking Analysis (NTA)
NTA was performed with a NanoSight LM20 (NanoSight,
Amesbury, UK). The instrument was equipped with a
405 nm blue laser, a sample chamber and a Viton
fluoroelastomer O-ring. If sample dilution was necessary to
achieve an optimal concentration for NTA, Milli-Q® water
was used as a diluent and all results were calculated back to the
original concentration. Samples were loaded into the sample
chamber by using a 1-mL syringe and a pre-run volume of
0.5 mL. Samples were analyzed in triplicate at a stopped flow,
while 0.1 mL was flushed through the chamber between each
repetition. The NTA 2.3 software was used for capturing and
analyzing the data. Movements of the particles in the samples
were recorded as videos for 60 s, while the shutter and gain
settings of the camera were set automatically by the software
for an optimal particle resolution.
UV-spectroscopy
UV-spectroscopy was performed in UV-transparent 96-well
plates (Corning Incorporation, NY, USA) by using a Tecan
Safire2 plate reader (Tecan Austria GmbH, Grödig, Austria).
For each data point, 200 μL of sample was measured in trip-
licate, each measurement being an average of 20 reads.
Fluorescence Spectroscopy
Fluorescence spectroscopy was performed in black 96-well
plates (Corning Incorporation, NY, USA) by using a Tecan
Safire2 plate reader (Tecan Austria GmbH, Grödig, Austria).
Excitation and emission of a 200-μL sample were 3D-scanned
in triplicate, each measurement being an average of 20 reads
from 250 to 460 and 290 to 600 nm, respectively.
Scanning Electron Microscopy Coupled
Energy-Dispersive X-ray Spectroscopy (SEM-EDX)
SEM-EDX measurements were performed with a Jeol JSM-
6500F instrument (Jeol, Tokyo, Japan) equipped with a silicon
drift detector (Oxford Instruments, Abingdon, U.K.). For
preparation 90 μL of each sample was dried under vacuum
and at room temperature on top of a sterile plastic coverslip
(Nunc Thermo Scientific, Schwerte, Germany), which was
fixed onto a SEM-sample holder with an electrically
conducting double-sided tape (Plano, Wetzlar, Germany). A
self-sticking copper band (Plano) was used to electrically con-
nect the sample surface to the sample holder base. The sample
surface was then carbon-coated by using a Bal-TecMED-020
carbon evaporator (Bal-Tec, Wetzlar, Germany).
Fourier Transform Infrared Microscopy (FTIR)
FTIRmeasurements were performed on dried samples with a
Bruker Hyperion 3000 FTIR microscope equipped with an
attenuated total reflection (ATR) objective (Bruker Optics,
Ettlingen, Germany) operated by the Bruker Opus 6.5 soft-
ware. Samples were dried and prepared as described for
SEM-EDX analysis, but without the application of a copper
band and without carbon coating.
RESULTS
Various sucrose products (Table I) were analyzed as 10%
solutions by DLS and all showed two distinct peaks in the
intensity-weighted size distribution (Fig. 1a). The position of
the first peak correlates to the literature value for the hydro-
dynamic diameter of a sucrose molecule in water of 0.98 nm
[10]. The second peak showed its intensity maximum at ca.
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100 to 200 nm for all samples except sucrose C, for which the
peak appeared at about 1900 nm. The relative intensity area
under the curve (AUC) of this signal varied considerably be-
tween samples, ranging from 8.3% for sucrose C to 60.3% for
sucrose A, while differences were observed between purity
grades, suppliers, and also between batches of the same sup-
plier (Table I). Also in NTA, a signal at about 100–200 nm
was detected with little variation in size distribution but high
variations in particle concentration between products (Fig. 1b,
Table I). Furthermore, an increase in concentration of sucrose
A in water resulted in a linear increase in nanoparticle
concentration determined by NTA, while a water control
did not show any particles (Fig. 1c). Furthermore, the size
distribution did not change with increasing sucrose concentra-
tion. Additionally, triplicate sample preparations analyzed by
DLS and NTA showed high repeatability (data not shown).
IgG and lysozyme formulated at various concentrations in
7% sucrose A solutions were analyzed by DLS. At an IgG
concentration of 0.1 mg/mL, the signal from the sucrose mol-
ecule (1 nm), the IgG (14 nm) and the 100–200 nm signal were
visible (Fig. 1d, upper panel). At 1 mg/mL, the 100–200 nm
signal disappeared and at 5 mg/mL also the sucrose signal
Table I Sucrose products used in this study and DLS and NTA results of (10% w/v) sucrose in solution. Numbers show mean values of triplicate
measurements

















Sucrose A Sigma ACSa SLBD1571V 13.7 0.95 247 0.9 133 27.9 94 158 246
Sucrose B Sigma Ph.Eur.b SZBC012V 4.3 0.35 160 0.9 134 7.1 82 131 238
Sucrose C Merck Ph.Eur. K42570987144 1.3 0.12 147 1.0 1899 0.7 96 160 312
Sucrose D Merck Ph.Eur. K38684287934 2.4 0.20 151 0.9 216 2.8 91 147 276
Sucrose E Südzucker Ph.Eur. L115310600 15.4 0.24 161 0.9 188 3.0 95 161 267
Sucrose F Caelo Ph.Eur. 12241808 4.2 0.34 157 0.9 139 4.9 81 122 206
Sucrose G VWR Ph.Eur. 13C190006 10.0 0.58 182 1.1 202 27.9 94 153 237
a Purity meets or exceeds the standards of the American Chemical Society b Purity meets or exceeds the requirements of the current European Pharmacopeia
c Polydispersity index
Fig. 1 (a) Intensity-weighted size
distribution by DLS and (b) particle
size distribution by NTA obtained
for different sugars in aqueous
solution at 10%. (c) Total particle
concentration (insert) and particle
size distribution obtained by NTA
for sucrose A solution from 0 to
10%. (d) Intensity-weighted size
distribution by DLS for 7% sucrose
A solutions containing increasing
concentrations of IgG (upper panel)
and lysozyme (lower panel). Shown
are mean values (a-d) plus standard
deviations (b and d) obtained from
triplicate measurements.
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(1 nm) vanished, leaving only the signal from the IgG. For
lysozyme (Fig. 1d, lower panel), the 100–200 nm signal was
detected in presence of all tested protein concentrations (0.1–
5 mg/mL), while the signal of the sucrose molecule and lyso-
zyme likely overlapped at about 1–2 nm because of the poor
resolution of DLS [13].
Solutions of sucrose B were filtered through filters with
decreasing pore size and subsequently analyzed by DLS and
NTA (Fig. 2a and b). Filtering the solutions through a 0.1-μm
filter had a small effect on the size, and little to no effect on the
intensity of the 100–200 nm signal. However, filtration
through a 0.02-μm filter decreased the signal in both DLS
and NTA to background levels and the signal did not reap-
pear after incubation of the filtered sample for 4 days at 25°C
(T1). Moreover, it was possible to eliminate the signal from the
sucrose monomer peak in a sucrose G solution by using
diafiltration (Fig. 2c). The purified retentate (before concen-
trating) maintained a stable size distribution and nanoparticle
concentration when incubated at 25°C for 4 days, as deter-
mined by DLS and NTA (Fig. 2d).
Upon concentration of the diafiltrated sucrose G retentate
containing the nanoparticle fraction, the sample developed a
brownish-yellow color and showed an increase in UV420nm
absorbance from 0.03 to 0.18 AU. A water control treated
the same way as the sucrose G sample showed no particles by
DLS and NTA and had an unchanged UV420nm absorbance
of 0.02 AU after concentration. Intrinsic fluorescence of the
concentrated sample was analyzed to help identifying poten-
tial colorants. The fluorescence intensity landscape is shown in
Fig. 3. Two distinct patterns of maximum fluorescence inten-
sity could be identified in the sample, pattern 1 at ca. 280/
390 nm (λEx/λEm) and pattern two at ca. 340/420 nm. The
water control treated equally did not show any intrinsic flores-
cence (data not shown).
When the concentrated particle suspension, derived from
sucrose G, was vacuum-dried, a thin and compact film layer
formed, which did not show any particulate structures by
SEM analysis. Rather, the film layer swelled and subsequently
ruptured upon extended exposure to the SEM beam, suggest-
ing water entrapment and thus potentially hygroscopic behav-
ior (Figure S1). No particulate matter was visible by SEM on a
vacuum-dried 0.02-μm filter after passing through the con-
centrated nanoparticle suspension (data not shown). Analysis
of the film layer by EDX, however, revealed the presence of
several minerals and metals. Signals from silicium, aluminum,
calcium, and magnesium were detected, as well as small
amounts of phosphor, sulfur, potassium, and iron (Fig. 4).
The control sample, water processed equally, showed small
amounts of silicium and calcium. Carbon, oxygen, and hydro-
gen signals were also detected, but are method derived and
cannot be attributed to the sample.
FTIR microscopy was performed on the vacuum-dried
sample to detect and identify potential organic material
(Fig. 5). An FTIR spectrum was obtained that, when
Fig. 2 (a) Intensity-weighted size
distribution by DLS and (b) particle
size distribution by NTA obtained
for sucrose B solutions (10%) after
filtration (stated pore size) and
storage for 4 days at 25°C (T1). c
Intensity-weighted size distribution
of a 10% sucrose G solution before
and after diafiltration and
subsequent upconcentration as
determined by DLS. D) Intensity-
weighted size distribution by DLS
and particle size distribution by NTA
(insert) of a diafiltrated 10% sucrose
G solution stored at 25°C.
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compared with the S.T. Japan-Europe GmbH library from
2009, matched closest the spectra of high-molecular-weight
dextran (40 kDa, entry# 2130) and cross-linked dextran
(Sephadex®G-50, 1.5–30 kDa, entry# 8096), with a hit qual-
ity of 626 and 620, respectively, with 1000 being a perfect
match. Unprocessed sucrose G powder provided an FTIR
spectrum that matched that of powdered sucrose (entry#
9772), with a hit quality of 959.
DISCUSSION
The interference of sugar-containing solutions with DLS anal-
ysis has been observed previously and manifests itself through
an additional signal at ca. 100–200 nm, besides the signal at
about 1 nm originating from the sugar monomer [11, 14]. In
our study, we found this second signal in solutions of a variety
of different sugars (trehalose, fructose, maltose and galactose,
data not shown) and different sucrose products (Fig. 1a),
confirming these previous observations. The 100–200 nm sig-
nal in DLS could mistakenly be interpreted as an aggregate peak and mask the formation/presence of protein aggregates.
Although this signal will disappear at higher protein concen-
trations, it should be noted that several antibody drugs are
formulated with a sugar at protein concentrations between 1
and 5 mg/mL [15], where the interference signal will likely
show up (Fig. 1d). Moreover, blinatumomab, recently ap-
proved by the FDA, is formulated at a concentration as low
as 12.5 μg/mL and several other protein therapeutics, such as
epoetins [16] and cytokines [17], are formulated at similarly
low concentrations. Furthermore, during early-stage formula-
tion development, proteins are often used at low concentra-
tions because of limited amounts of material available.
Up to now, the interference was suggested to be an intrinsic
phenomenon coming from the sugar molecules themselves.
However, if the 100–200 nm signal was indeed an intrinsic
phenomenon caused by the sugar molecules, one would ex-
pect the interference to be the same for solutions of the same
Fig. 3 Fluorescence intensity landscape of suspended nanoparticles isolated
from sucrose G. The arrows indicate areas of fluorescence maxima. The black
area showed strong light scattering and was excluded from the analysis.
Fig. 4 EDX spectrum of vacuum dried nanoparticle isolated from sucrose G
(sample) against a water control treated the same way (control). Element
analysis was performed against internal standards of the SEM-EDX system.
Fig. 5 FTIR spectra recorded by FTIR microscopy overlaid with the best
fitting entries of the S.T. Japan Europe GmbH database from 2009. (a) Re-
corded spectrum of vacuum dried nanoparticles isolated from sucrose G
(blue) overlaid with the entries of high-molecular-weight (red) and cross-linked
dextran (violet). (b) Recorded spectrum of unprocessed sucrose G (blue)
overlaid with the entry of powdered sucrose (red).
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sugar concentration. In contrast, our results could demon-
strate high variability of this interference for sucrose across
purity grades, suppliers, and also across batches of the same
supplier. Further, one batch supplied by Merck (sucrose C)
showed this signal to a barely detectable, very low extent
and the signal also deviated in size from that of the other
products (Table I). Altogether, this indicates that the interfer-
ence is caused by particulate matter rather than by monomer-
ic sucrose molecules.
Besides DLS, also NTA detected particles at 100–200 nm
showing high variability in particle concentration between the
different sucrose products (Fig. 1b). Furthermore, the particle
concentrations determined by NTA correlate, in relative
terms, well with the polydispersity index and the derived count
rate determined by DLS using a fixed attenuator (Table I).
Thus, the particles detected by NTA are likely the same as
those causing the signal in DLS. It should be noted that su-
crose, lysozyme and IgG monomers are below the lower size
limit of NTA [18]. However, they are detected by DLS, but
their signal can in some cases, when a large protein such as an
IgG is formulated at high concentration, decrease or even
disappear in DLS analysis (Fig. 1d). Profound evidence that
the presence of suspended particles is responsible for the in-
terference signal comes from the results shown in Fig. 2a and
b, where this signal in DLS and NTA disappeared after ultra-
filtration (0.02 μm). The signal did not re-emerge from the
remaining sucrose molecules in solution over the observed
time frame of 4 days, suggesting an origin other than an in-
trinsic phenomenon of the sucrose molecules. After purifica-
tion by diafiltration, the nanoparticles likely responsible for
the interference did not dissolve or further agglomerate to
larger particles, at least not readily, when stored in water,
supporting the theory of the presence of stable and potentially
foreign particulates (Fig. 2d).
Following the indication that the nanoparticles might be
partially or fully composed of impurities or contaminants, a
detailed chemical analysis of the nanoparticles was attempted.
No particle like structures could be visualized by SEM analysis
of a vacuum-dried particle suspension, because the sample
preparation resulted in the formation of a film layer. Howev-
er, the presence of inorganic elements was determined in this
layer by the SEM coupled EDX analysis (Fig. 4). The combi-
nation of detected elements closely matches the description of
an inorganic contaminant called ash, which is a combination
of chlorides, sulfates, phosphates, silicates andminerals includ-
ing calcium, potassium, magnesium and aluminum, mostly
present as salts or oxides, as well as clay and sand [19]. Ash
can enter the sugar cane or beet during growth from the soil,
water and added fertilizers, but can also be introduced to the
unprocessed sugar by external matter such as dirt or trash. Ash
therefore commonly contaminates the unprocessed cane or
beet juice, however, to various degrees and with slight differ-
ences in composition depending on the producer. Even
though ash is largely cleared off by current refinement pro-
cesses, an effective removal of ash components in refined white
sugar products is still challenging for the sugar industry [20].
In the dried particle suspension, we could also detect dex-
tran structures by ATR-FTIR microscopy (Fig. 5a). The data
suggest that dextran is present as cross-linked fibers, likely
responsible for the formation of the hygroscopic film layer
upon drying the particles. Dextran is a well-known impurity
in the sugar industry, produced due to enzymatic deteriora-
tion by Leuconostoc bacteria, which mainly enter the sugar cane
or beet during harvesting, cutting and grinding, but can also
be introduced in later production steps [21]. The dextran
content in the unprocessed cane or beet juice, however, can
vary significantly between different producers, depending
amongst others on the delay time between cutting and
milling, the harvesting method, the refinement process,
and the overall hygiene [22]. Importantly, investigations
have shown that dextran is not completely removed by
current sugar refinement processes [23, 24].
It should be noted that both, ash and dextran, are essential
components of molasses, a side product of sugar refinement
giving brown sugar its distinct color. U.S. and European phar-
macopeias require a color test and also UV absorbance data
at 420 nm to specifically test pharmaceutical-grade sucrose for
molasses remains. As described in the results section, we ob-
served a brownish-yellow color and an increased UV absor-
bance at 420 nm after concentrating the nanoparticle impu-
rities. The nanoparticle impurities further possessed fluores-
cence activity in two distinct regions (Fig. 3). Diverse amounts
of fluorescent impurities of different compositions have been
found in various sugar products by other research groups [20,
25–29]. According to these studies, the observed fluorescence
patterns are caused by a combination of various fluorophores,
two of which have close similarities with tryptophan and tyro-
sine and could be responsible for the fluorescence pattern one
at ca. 280/390 nm [25–27]. Other fluorophores were identi-
fied as catechols formed by base-catalyzed sugar degradation
and again other are suggested being Maillard reaction poly-
mers, all of which could be potential contributors to the fluo-
rescence pattern 2 [28, 29]. Fluorescent impurities can
be found in various sugar products, however, in different
compositions and quantities.
Dextran impurities found in sucrose occur in a wide
molecular-weight-range from a few kDa to several MDa
[21, 22], while the ash components detected by EDX and
the components suggested by fluorescence spectroscopy are
likely much smaller in size. Interestingly, all of those were
found in the same particle population with a consistent size
of 100–200 nm. Thus, two questions arise from there: i) How
do the various impurities come together to form particles and
ii) why do these particles occur in such a defined size distribu-
tion, even across various producers? A potential answer to
these questions lies in the sugar refinery process itself,
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particularly in the carbonation or phosphatation step. Here,
calcium carbonate or calcium phosphate, respectively, is
formed, which co-precipitates with high-molecular-weight
components and suspended solids [20]. During this step, ag-
glomeration of dextran and other impurities and contami-
nants could lead to the formation of suspended nanometer
sized particles. After the precipitation, the sugar juice is usually
clarified by filtration where the membrane’s cutoff might be
responsible for the defined size distribution of the nanoparticle
impurities.
While the exact particle formation process is still rather
speculative, it is worth discussing potential ways to deal with
nanoparticle impurities in sugars. On the one hand, this could
be attempted analytically. For measurements performed by
DLS, however, it is not possible to mathematically calculate
or subtract the contribution of the nanoparticle impurities
from the signal. For measurements performed by NTA, a
simple subtraction of the particle counts in the placebo buffer
from the particle counts in the sample is possible. Neverthe-
less, it needs to be noted that the concentration of nanoparticle
impurities at pharmaceutically relevant sucrose concentra-
tions can exceed protein particle concentrations even in de-
graded samples by several orders of magnitude, making sim-
ple buffer subtraction statistically meaningless. On the other
hand, a pharmaceutical manufacturer could get rid of the
nanoparticles through the filtration of sucrose solutions using
small pore size filters (e.g., 0.02-μm pores) with commonly
available systems for production scale ultrafiltration. It would
also be beneficial to improve the sugar refinement processes in
order to reduce the amount of impurities in the final sugar
product, as has been suggested by various research groups
[19–23, 30]. To ensure effectiveness, however, it would then
require monographs to include a test for nanoparticulate im-
purities in pharmaceutical-grade sugar products.
CONCLUSIONS
In this study we demonstrated that sugar, even in
pharmaceutical-grade quality, can contain up to 109 nanopar-
ticles per gram in the 100–200 nm range, which can limit the
use of techniques for subvisible particle analysis, such as DLS
and NTA. The number of nanoparticles can vary significantly
between suppliers, as well as between production batches.
This makes it very challenging to compare aggregation states
of proteins in sugar-containing formulations by DLS and
NTA, especially during formulation development. Our results
indicate that the nanoparticles found in sucrose are agglom-
erates of a variety of impurities (dextrans, ash and aromatic
colorants) that were not entirely removed during refinement
processes. Importantly, the presence of these nanoparticulate
impurities is not taken into consideration by pharmacopeial
quality criteria. Furthermore, the nanoparticle impurities
cannot be removed by common sterile filtration using a
0.22-μm pore size filter. However, ultrafiltration could be an
effective way to clear the nanoparticles from sucrose solutions.
Whether the particles observed in sugars other than sucrose
are composed similarly and whether or not these impurities
have an impact on a protein’s overall stability is currently
unknown and is the subject of ongoing follow-up studies.
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